Literature DB >> 28439954

Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism.

S Barco1,2, M Corti2, A Trinchero1,2, C Picchi2,3, C Ambaglio2, S V Konstantinides1,4, F Dentali5, M Barone2.   

Abstract

Essentials The long-term risk of recurrence and death after distal deep vein thrombosis (DVT) is uncertain. We included subjects with first proximal or isolated distal DVT (IDDVT) and no pulmonary embolism. The risk of symptomatic and asymptomatic recurrence is lower after IDDVT (vs. proximal). IDDVT may be associated with a lower long-term risk of death, especially after unprovoked DVT.
SUMMARY: Background A few studies have focused on the risk of recurrence after first acute isolated distal deep vein thrombosis (IDDVT) compared with proximal DVT (PDVT), whereas the incremental risk of death has never been explored beyond the first 3 years after acute event. Methods Our single-center cohort study included patients with first symptomatic acute PDVT or IDDVT. Patients were excluded if they had concomitant pulmonary embolism (PE) or prior venous thromboembolism. The primary outcomes were symptomatic objectively diagnosed recurrent PDVT or PE and all-cause death. Results In total, 4759 records were screened and 831 subjects included: 202 had symptomatic IDDVT and 629 had PDVT. The median age was 66 years and 50.5% were women. A total of 125 patients had recurrent PDVT or PE during 3175 patient-years of follow-up: 109 events occurred after PDVT (17.3%) and 16 after IDDVT (7.9%). Annual recurrence rates were 4.5% (95% confidence interval [CI], 3.7-5.4%) and 2.0% (95% CI, 1.1-3.2%), respectively, for an adjusted hazard ratio (aHR) for IDDVT patients of 0.32 (95% CI, 0.19-0.55). Death occurred in 263 patients (31.6% [95% CI, 28.6-34.9%]) during 5469 patient-years of follow-up for an overall annual incidence rate of 4.8% (95% CI, 4.2-5.4%). The mortality rate was 33.5% (n = 211) in PDVT patients and 25.7% (n = 52) in IDDVT patients. The long-term hazard of death appeared lower for IDDVT patients (aHR, 0.75 [95% CI, 0.55-1.02]), especially after unprovoked events (aHR, 0.58 [95% CI, 0.26-1.31]). Conclusions Compared with PDVT, IDDVT patients were at a lower risk of recurrent VTE. The risk of death appeared lower after IDDVT during a median follow-up of 7.6 years.
© 2017 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  anticoagulation; death; distal deep vein thrombosis; pulmonary embolism; venous thromboembolism

Mesh:

Year:  2017        PMID: 28439954     DOI: 10.1111/jth.13713

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  13 in total

1.  Risk and incidence of perioperative deep vein thrombosis in patients undergoing gastric cancer surgery.

Authors:  Tomohiro Osaki; Hiroaki Saito; Yoji Fukumoto; Yusuke Kono; Yuki Murakami; Yuji Shishido; Hirohiko Kuroda; Tomoyuki Matsunaga; Kengo Sato; Yasuaki Hirooka; Yoshiyuki Fujiwara
Journal:  Surg Today       Date:  2017-12-12       Impact factor: 2.549

2.  Management of isolated distal deep-vein thrombosis with direct oral anticoagulants in the RIETE registry.

Authors:  Jean-Philippe Galanaud; Javier Trujillo-Santos; Behnood Bikdeli; Pierpaolo Di Micco; Cristiano Bortoluzzi; Laurent Bertoletti; José María Pedrajas; Aitor Ballaz; Joaquín Alfonso; Manuel Monreal
Journal:  J Thromb Thrombolysis       Date:  2020-11-28       Impact factor: 2.300

3.  Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.

Authors:  Behnood Bikdeli; César Caraballo; Javier Trujillo-Santos; Jean Philippe Galanaud; Pierpaolo di Micco; Vladimir Rosa; Gemma Vidal Cusidó; Sebastian Schellong; Meritxell Mellado; María Del Valle Morales; Olga Gavín-Sebastián; Lucia Mazzolai; Harlan M Krumholz; Manuel Monreal
Journal:  JAMA Cardiol       Date:  2022-08-01       Impact factor: 30.154

4.  Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer.

Authors:  F Dentali; S Barco; S Pegoraro; M N D Di Minno; D Mastroiacovo; F Pomero; C Lodigiani; F Bagna; M Sartori; G Barillari; N Mumoli; M Napolitano; S M Passamonti; R Benedetti; W Ageno; M Di Nisio
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

5.  The effect of anticoagulants on venous thrombosis prevention after knee arthroscopy: a systematic review.

Authors:  Hai-Feng Huang; Jia-Liang Tian; Li Sun; Xian-Teng Yang; Yu-Kun Shen; Shan-Shan Li; Quan Xie; Xiao-Bin Tian
Journal:  Int Orthop       Date:  2018-10-30       Impact factor: 3.075

6.  Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study.

Authors:  Sebastian Schellong; Walter Ageno; Ivan B Casella; Kok Han Chee; Sam Schulman; Daniel E Singer; Marc Desch; Wenbo Tang; Isabelle Voccia; Kristina Zint; Samuel Z Goldhaber
Journal:  Semin Thromb Hemost       Date:  2021-05-10       Impact factor: 6.398

Review 7.  Characteristics and Treatment Strategy of Isolated Calf Deep Venous Thrombosis after Fractures: A Review of Recent Literature.

Authors:  Wei-Guang Zhao; Ji-Ying Yan; Xiao-Lei Li; Cai-Ying Shi; Zhi-Yun Wang; Wei Guo; Kai Zhang; Wei-Li Zhang; Xiao-Chuan Jia; Shu-Bei Cui; Li-Qiang Jiang; Jian-Long Zhao; Zhen-Wu Liu; Zhao-Hui Yang; Li Liu; Ying-Ze Zhang
Journal:  Orthop Surg       Date:  2022-04-28       Impact factor: 2.279

8.  Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: A meta-analysis.

Authors:  Hai-Feng Huang; Jia-Liang Tian; Xian-Teng Yang; Li Sun; Ru-Yin Hu; Zhi-Hui Yan; Shan-Shan Li; Quan Xie; Xiao-Bin Tian
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

9.  Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total knee arthroplasty: A meta-analysis.

Authors:  Hai-Feng Huang; Shan-Shan Li; Xian-Teng Yang; Quan Xie; Xiao-Bin Tian
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

10.  Current and future burden of venous thrombosis: Not simply predictable.

Authors:  Luuk J J Scheres; Willem M Lijfering; Suzanne C Cannegieter
Journal:  Res Pract Thromb Haemost       Date:  2018-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.